Actions
  • shareshare
  • link
  • cite
  • add
add
Research data . Clinical Trial . 2014

Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)

Silverman, Robert;
Open Access
Published: 16 Sep 2014
Publisher: nct
Abstract

Randomized, Placebo-Controlled, Phase 3 Trial of RHB-102 (BEKINDA) (Ondansetron 24 mg Bimodal Release Tablets) for Acute Gastroenteritis. The study will evaluate the safety and efficacy of RHB-102 (BEKINDA) in treating Acute Gastroenteritis, by comparing it to placebo.

Download from
lock_open
OpenTrials
Clinical Trial . 2014
Providers: OpenTrials
moresidebar